---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-023628"
form_type: "8-K"
ticker: "LIXT"
cik: "0001335105"
company_name: "LIXTE BIOTECHNOLOGY HOLDINGS, INC."
filed_at: "2025-08-14T23:59:59+00:00"
generated_at: "2026-05-17T12:57:54.870889+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Lixte Biotechnology updates treasury policy to allocate up to 25% to Bitcoin and other digital assets

## Summary
- Board approved allocating up to 25% of corporate treasury to cryptocurrencies including Bitcoin.
- Company will hold crypto assets with a fully regulated and compliant custodian.
- CEO Geordan Pursglove cites long-term potential to hedge treasury and deliver shareholder returns.
- Timing and size of purchases will depend on market conditions; policy retains flexibility.
- Lixte is a clinical-stage biotech; treasury policy shift is a strategic capital allocation initiative.

## SEC filing metadata
- accession: 0001641172-25-023628
- form_type: 8-K
- ticker: LIXT
- cik: 0001335105
- company_name: LIXTE BIOTECHNOLOGY HOLDINGS, INC.
- filed_at: 2025-08-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1335105/000164117225023628/0001641172-25-023628-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1335105/000164117225023628/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-023628
- JSON: https://secwatch.observer/filing/0001641172-25-023628.json
- Plain text: https://secwatch.observer/filing/0001641172-25-023628.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.